Concepedia

Chi-Jung Wu

CW

Statistics

Publications

9

Citations

399

H-Index

9

Active since

2020

Affiliations

National Yang Ming Chiao Tung University(Current)

Taipei Veterans General Hospital

National Taiwan University

National Health Research Institutes

E-Da Hospital

Chi-Jung Wu is an author at National Yang Ming Chiao Tung University specializing in oncology, medicine, and surgical oncology.

Publications per year

2020–2025

9

Publications

9

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma

Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung et al. · Journal for ImmunoTherapy of Cancer · 2022 · 197 citations · Full text

Life Sciences, Microbiology, Oncology +17

Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma

Chi-Jung Wu, Pei‐Chang Lee, Ya‐Wen Hung et al. · Cancer Immunology Immunotherapy · 2022 · 43 citations · Full text

Medicine, Oncology, Pharmacology +13

Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy

Hsien-Chen Mon, Pei‐Chang Lee, Yi‐Ping Hung et al. · Journal of Hepatology · 2024 · 34 citations · Full text

Medicine, Immunology, Oncology +17

Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg.

I‐Cheng Lee, Hao‐Jan Lei, Gar‐Yang Chau et al. · PubMed · 2021 · 30 citations · Full text

Medicine, Oncology, Surgery +14

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab

Ying‐Chun Shen, Tsung‐Hao Liu, Alan Nicholas et al. · Journal of Clinical Oncology · 2024 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 9